ArticleCell reports2026

Surface and global proteomics identify ROR2 and other proteins as potentially actionable immunotherapeutic targets in osteosarcoma.

Brian Mooney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.